###### Strengths and limitations of this study

-   To the best of our knowledge, this study represents the first review evaluating the combined effects of vitamin D~3~ supplementation and exercise in older adults.

-   Generally, outcome measure data could be graded as representing moderate quality.

-   Only seven studies were found to be eligible for inclusion, highlighting the lack of literature available on the topic.

-   The inclusion of one high-risk study was deemed necessary due to the lack of eligible studies.

Introduction {#s1}
============

Sarcopenia, originally defined as the age-related loss of muscle mass,[@R1] now also encompasses low muscle strength and/or muscle function.[@R2] The efficacy of resistance training in preventing or alleviating age-related musculoskeletal loss is well established; cited as the most promising intervention for improving symptoms of sarcopenia.[@R3]

Clear evidence exists demonstrating an association between resistance exercise training (RET) and muscle hypertrophy, which is maintained in older age.[@R3] However, in older adults there is a blunted responsiveness to RET in comparison with younger adults; a blunted muscle protein synthetic rate in response to a single bout of resistance exercise has been reported,[@R6] and others demonstrate a reduction in muscle hypertrophy in comparison to younger adults.[@R7] This 'anabolic resistance' may be due to changes in gene expression and anabolic signalling; an attenuated anabolic hormone response to resistance exercise is observed in comparison to younger adults.[@R11]

Losses in muscle strength are associated with losses in functional ability, independence and increases in frailty, falls and disability in older adults[@R12]; therefore, there may be merit associated with a combination of interventions to boost responsiveness of older muscle to resistance exercise and combat anabolic resistance.

Vitamin D~3~ supplementation in humans has been shown to positively influence musculoskeletal health in older adults: increases in relative number and cross-sectional area (CSA) of muscle fibres (type II in particular) has been reported,[@R16] and muscle strength increased and fall rates decreased after treatment with vitamin D~3~.[@R17] Vitamin D receptor concentration significantly increased with vitamin D~3~ supplementation[@R18]; conversely, supplementation conferred no benefits on strength, functioning and balance.[@R19] Moreover, a systematic review examining the effects of vitamin D~3~ supplementation in vitamin D replete adults aged over 18 years found no significant effect on grip or proximal lower limb muscle strength; however, pooled data including vitamin D deficient participants (serum 25(OH)D \<25 nmol/L) demonstrated a large effect on hip muscle strength.[@R22]

There is conflicting evidence surrounding the efficacy of vitamin D~3~ supplementation alone or in combination with exercise on musculoskeletal health, with no clear consensus regarding the management or prevention of sarcopenia. Although epidemiological data suggest a relationship between vitamin D~3~ and muscle weakness,[@R23] this association is not well understood, and evidence in published literature is lacking and contradictory. Considering the beneficial effects of both RET and vitamin D~3~ on muscle tissue, it is plausible an additive effect would exist if combined, optimising the potential for healthy ageing muscle.[@R24] Thus, the aim of this study was to assess the combined effect of RET and vitamin D~3~ supplementation on musculoskeletal health in older adults.

Materials and methods {#s2}
=====================

A systematic review of peer-reviewed literature relating to the effect of RET and vitamin D~3~ supplementation on musculoskeletal health in older adults was conducted in accordance with a study protocol registered on the PROSPERO database (record number CRD42015020157). The protocol was informed by the Cochrane Handbook for Systematic Reviews of Interventions,[@R25] and reporting conformed to the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement.[@R26]

Eligibility criteria {#s2a}
--------------------

Randomised controlled trials were sought for this study. Journal studies included: (1) male and/or female participants (aged ≥65 years or mean age ≥65 years), (2) enlisted RET and vitamin D~3~ supplementation (studies using vitamin D~3~ and calcium supplementation were included), (3) included measures of muscle strength, function, muscle power, body composition, serum vitamin D/calcium status or quality of life, (4) compared results with a control group (sedentary/usual care/no vitamin D~3~ supplementation). Articles were excluded if participants were supplemented with additional protein or any supplement/medication with a known anabolic effect on muscle tissue.

Search methods for identification of studies {#s2b}
--------------------------------------------

Articles published before March 2016 were included. A computerised search of Science Direct, Medline, PubMed, Google Scholar and Cochrane Central Register of Controlled Trials (Cochrane CENTRAL accessed by Wiley Science) databases was conducted. [Table 1](#T1){ref-type="table"} shows the Medline search strategy, devised by AEA and LH.

###### 

Example Ovid Medline search, to be adapted for other databases

  ---- --------------------------------------------------------------------------------------------------------------------------
  1    Aging/
  2    Exp aged/
  3    (65 adj2 (years or age\* or old\*))
  4    (old\* adj (adult\* or people or person\* or population\* or men or women))
  5    (elder\* or senior\* or geriatric\* or ?enarian or ag?ing)
  6    ((age\* or aging or old\* or elder\*) adj1 (musc\*))
  7    1 or 2 or 3 or 4 or 5 or 6
  8    Vitamin D/
  9    (cholecalciferol\* or calciferol\* or ergocalciferol\*)
  10   (supplements or dietary supplements)
  11   ((vitamin D\* or cholecalciferol or calciferol\* OR ergocalciferol) adj supplementation)
  12   8 or 9 or 10 or 11
  13   Muscle Development/
  14   Muscle, Skeletal/
  15   (Skeletal muscle adj2 (atrophy or sarcopenia or wasting or loss or deterioration))
  16   Muscle Strength/
  17   (skeletal muscle mass or size or fibres or fibers or area)
  18   (musc\* adj2 (function\* or power or strength))
  19   (musc\* adj2 (grow\* or hypertrophy or size or mass or csa or cross sectional area or volume))
  20   Body Composition/
  21   (lean adj3 mass)
  22   (protein adj2 (turnover or synthesis or breakdown))
  23   (nitrogen adj2 (balance or turnover or synthesis or breakdown or retention or loss or retain\*))
  24   Sarcopenia/
  25   13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
  26   Exp exercise/
  27   (resistance exercise or resistance exercise training)
  28   ((resistance or strength or weight or cardio or aerobic) adj3 (train\* or condition\* or exercise\* or lift\*))
  29   (physical adj3 (activit\* or exercise\* or train\* or exertion\* or endurance\* or therap\* or conditioning or fitness))
  30   (exercise adj3 (train\* or intervention\* or protocol\* or program\* or therap\* or regim\* or activit\*))
  31   26 or 27 or 28 or 29 or 30
  32   7 and 12 and 25 and 31
  33   Limit 32 to humans
  34   Remove duplicates from 33
  ---- --------------------------------------------------------------------------------------------------------------------------

Data items and collection {#s2c}
-------------------------

Data were extracted independently by two reviewers (AEA and ASA) using a standardised data extraction sheet; any disagreements were discussed and resolved with a third person (CAG). The inter-rater reliability assessed using Cohen's Kappa, was found to be excellent (86% agreement).[@R27] Data items including general information, participant characteristics and details of the intervention were extracted. For key outcomes, the definition used by the authors, methodology, results, mean differences and the presence/absence of statistical significance were reported.

Risk of bias analysis {#s2d}
---------------------

Two reviewers (AEA and CAG) independently assessed the validity of included studies, with provisions for moderation from a third reviewer. The Cochrane Collaboration's tool for assessing risk of bias was used, as described in the Cochrane Handbook for Systematic Reviews of Interventions[@R25] ; the use of scales for assessment is explicitly discouraged.[@R28] Prespecified consensus points were devised and agreed by reviewers to ensure consistency. It was acknowledged that by nature of design, blinding of participants and personnel would be difficult in certain studies; therefore, grading was based on the likelihood that outcome measures were influenced by the potential lack of blinding.[@R25]

Grading the quality of evidence {#s2e}
-------------------------------

The Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) handbook[@R30] was used to evaluate the quality of evidence of outcomes assessed within the meta-analyses. The GRADE approach uses systematically produced questions to reach conclusions on degree of confidence in the estimate of the effect. GRADE assesses patient important outcomes across five areas: risk of bias, inconsistency, indirectness, imprecision and publication bias and grades outcomes as demonstrating high, moderate, low or very low quality of evidence.

Results {#s3}
=======

Study selection {#s3a}
---------------

Seven studies were included within the review: Agergaard *et al* [@R31], Bunout *et al* [@R32], Drey *et al* [@R33], Gianoudis *et al* [@R34], Jessup *et al* [@R35], Uusi-Rasi *et al* [@R21] and Verschueren *et al* [@R36]; the study flow diagram is presented in [figure 1](#F1){ref-type="fig"}.

![Study flow chart.](bmjopen-2016-014619f01){#F1}

On reading full-text articles, it became clear that there were two separate groups of interventions; group 1, in which all participants took part in RET and the intervention arm was supplemented with vitamin D~3~ (describing the additive effect of vitamin D~3~ supplementation when combined with resistance exercise training), group 2 in which all participants were supplemented with vitamin D~3~ and the intervention arm took part in RET (describing the additive effect of resistance exercise training when combined with vitamin D~3~ supplementation); and studies using a combination of the two interventions ([table 2](#T2){ref-type="table"}).

###### 

Study demographics

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                       N included in analyses                                                                                        Mean age (y)   Sex (M:F)   Study design   Intervention group protocol                                           Control group protocol                                                Duration
  ---------------------------------- ------------------------------------------------------------------------------------------------------------- -------------- ----------- -------------- --------------------------------------------------------------------- --------------------------------------------------------------------- -----------
                                     Group 1: all participants exercised, intervention group received vitamin D supplementation                                                                                                                                                                                                          

  Agergaard *et al*, 2015 [@R31]     17                                                                                                            66.9           17:0        RCT            RET\                                                                  RET\                                                                  16 weeks
                                                                                                                                                                                             3x per week\                                                          3x per week\                                                          
                                                                                                                                                                                             and\                                                                  and\                                                                  
                                                                                                                                                                                             1920 IU D3+800 mg Ca/day                                              800 mg Ca/day                                                         

                                     Group 2: all participants received vitamin D supplementation, intervention group exercised                                                                                                                                                                                                          

  Drey *et al*, 2011[@R33]           45                                                                                                            77             13:32       RCT            RET\                                                                  Sedentary\                                                            12 weeks
                                                                                                                                                                                             2×60 min per week\                                                    and\                                                                  
                                                                                                                                                                                             and\                                                                  \>20 ng/mL=1000 IU D3/day\                                            
                                                                                                                                                                                             \>20 ng/mL=1000 IU D3/day\                                            \<20 ng/mL=2000 IU D3/day                                             
                                                                                                                                                                                             \<20 ng/mL=2000 IU D3/day                                                                                                                   

  Gianoudis *et al*, 2014[@R34]      162                                                                                                           67             119:43      RCT            HV-PRT\                                                               Sedentary\                                                            12 months
                                                                                                                                                                                             3x per week\                                                          and\                                                                  
                                                                                                                                                                                             and\                                                                  1000 IU D3+700 mg Ca/day                                              
                                                                                                                                                                                             1000 IU D3+700 mg Ca/day                                                                                                                    

  Jessup *et al*, 2003 [@R35]        18                                                                                                            69             0:18        RCT\           RET\                                                                  Sedentary\                                                            32 weeks
                                                                                                                                                                              parallel       3×60--90 min per week\                                                and\                                                                  
                                                                                                                                                                                             and\                                                                  400 IU D3+1000 mg Ca/day                                              
                                                                                                                                                                                             400 IU D3+1000 mg Ca/day                                                                                                                    

  Verschueren *et al*, 2011 [@R36]   111                                                                                                           79             0:111       RCT            WBV\                                                                  Sedentary\                                                            6 months
                                                                                                                                                                                             3x per week\                                                          and\                                                                  
                                                                                                                                                                                             and\                                                                  High-dose=1600 IU\                                                    
                                                                                                                                                                                             High-dose=1600 IU\                                                    Or\                                                                   
                                                                                                                                                                                             Or\                                                                   Conventional dose=800 IU D3/day\                                      
                                                                                                                                                                                             Conventional dose=800 IU D3/day\                                      +1000 mg Ca/day                                                       
                                                                                                                                                                                             +1000 mg Ca/day                                                                                                                             

                                     Assigned to groups 1 and 2: participants took part in a combination of exercise and vitamin D interventions                                                                                                                                                                                         

  Bunout *et al*, 2006 [@R32]        92                                                                                                            77             9:83        RCT            RET\                                                                  RET\                                                                  9 months
                                                                                                                                                                                             2×1.5 hour per week Or sedentary\                                     2×1.5 hours per week Or sedentary\                                    
                                                                                                                                                                                             and\                                                                  and\                                                                  
                                                                                                                                                                                             400 IU D3+800 mg Ca/day                                               800 mg Ca/day                                                         

  Uusi-Rasi *et al*, 2015 [@R21]     409                                                                                                           74             0:409       RCT            RET 2x/week for 12 months, 1x/week for next 12 months or sedentary\   RET 2x/week for 12 months, 1x/week for next 12 months or sedentary\   2 years
                                                                                                                                                                                             and\                                                                  and\                                                                  
                                                                                                                                                                                             800 IU D3/day                                                         Placebo/day                                                           
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*RCT, randomised controlled trial, RET, resistance exercise training, IU, international units, Ca, calcium, HV-PRT, high-velocity progressive resistance training; WBV, whole body vibration.

Study demographics {#s3b}
------------------

Seven eligible studies included a total of 792 participants of mean age 72.8 years ([table 2](#T2){ref-type="table"}). Of these, one included only males[@R31] and three included only females.[@R21] All studies included healthy participants living independently, except for two studies[@R35]; included participants living within a retirement community and[@R36] included institutionalised participants living in nursing homes, service flats or cloistered communities.

Interventions {#s3c}
-------------

Studies assigned to group 1 included: Agergaard *et al* [@R31], Bunout *et al* [@R32] and Uusi-Rasi *et al* [@R21]. In group 1, all participants took part in RET; incorporating a warm-up and strengthening exercises using commercial weight machines[@R21] or Thera-bands.[@R31] Two studies included balance challenging aspects.[@R21] All studies included supervised, progressive exercise sessions; progression was monitored by a five rep max test,[@R31] Borg scale[@R32] or metabolic equivalents (METs).[@R21] Total number of sessions delivered ranged from 36[@R31] to 156,[@R21] over a duration of 16 weeks[@R31] to 24 months.[@R21] All administered a vitamin D~3~ supplement, orally in tablet form; doses ranged from 400 IU/day[@R32] to 1920 IU/day[@R31] ; in two studies participants were supplemented with 800 mg calcium per day[@R31] and one study supplemented the control group with a placebo.[@R21]

Six studies assigned to group 2 included: Bunout *et al* [@R32], Drey *et al* [@R33], Gianoudis *et al* [@R34], Jessup *et al* [@R35], Uusi-Rasi *et al* [@R21] and Verschueren *et al* [@R36]. Within group 2, all participants took a vitamin D~3~ supplement, orally in tablet form. Doses ranged from 400 IU/day[@R32] to 2000 IU/day[@R33]; one study monitored serum 25(OH)D at baseline to determine supplement dosage.[@R33] In four studies,[@R32] all participants were supplemented with calcium; doses ranged from 700 mg/day[@R34] to 1000 mg/day[@R35]. The intervention group took part in RET. Studies used machine weights and pulleys,[@R21] Thera-bands,[@R32] weighted vests[@R35] and whole body vibration machines[@R36] for resistance. Five studies included balance challenging aspects.[@R21] All studies employed supervised, progressive exercise sessions monitored via a Borg scale,[@R32] addition of weights to weighted vests,[@R35] estimation of METs or individual ability.[@R36] Total number of sessions delivered ranged from 24[@R33] to 156,[@R21] over a duration of 12 weeks[@R33] to 24 months.[@R21] Note that two studies included comparators which allowed allocation to both groups.[@R21]

Outcome measures {#s3d}
----------------

All outcomes are listed in [table 3](#T3){ref-type="table"}. Group 1 studies had few outcomes in common; however, all measured muscle strength[@R21]; isometric knee extensor strength was measured using a strain gauge[@R21] and isometric quadriceps strength was measured using a quadriceps table.[@R32] Hand grip strength was measured using a hand grip dynamometer.[@R32] MRI was used to measure the CSA of the quadriceps,[@R31] while[@R32] analysed fat and lean mass using dual-energy X-ray absorptiometry (DXA). Two studies measured timed up and go (TUG), femoral neck and spine bone mineral density (BMD).[@R21] One study analysed fibre type and muscle quality.[@R31]

Group 2 studies[@R21] assessed lower limb strength[@R32] and measured grip strength. Muscle power was measured as sit-to-stand transfer power[@R33] and the stair climb test.[@R34] The short physical performance battery (SPPB) was assessed by,[@R32] and the TUG by.[@R21] BMD of the femoral neck[@R21] and spine[@R21] were measured using DXA. Lean mass was measured using DXA[@R32] and X-ray CT.[@R36] Balance was assessed via the Romberg ratio,[@R32] four-square step test,[@R34] an AccuSway platform[@R35] and backwards walking.[@R21] Other outcomes included endurance (12 min walk[@R32]), the 30 s sit-to-stand test,[@R34] normal walking speed and the 5-time chair stand test.[@R21]

###### 

Summary of included study outcome measures and significant results

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                 Outcome measures    Significant results                                            
  ---------------------------- ------------------- -------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------
  Agergaard *et al* [@R31]     Muscle strength\    Isometric knee extensor (strain gauge)\                        Muscle strength: no between-group difference\
                               Muscle CSA\         MRI of quadriceps muscle (6 mm thick)\                         Muscle CSA: no between-group difference\
                               Muscle quality      Muscle strength/CSA                                            Muscle quality: N/S

  Bunout *et al* [@R32]        Muscle strength\    Quadriceps (table) and hand grip strength (dynamometer)\       Muscle strength: increased with exercise (p\<0.001), no effect of vitamin D\
                               Muscle function\    SPPB, TUG\                                                     Muscle function: SPPB increased with exercise (p=0.002), no effect of vitamin D, TUG: increased in both groups (p=0.004)\
                               BMD\                Femoral neck and spine (DXA)\                                  BMD: femoral neck increased with vitamin D, decreased without (p=0.006). Spine was N/S\
                               Body sway\          Romberg ratio\                                                 Body sway: lower with vitamin D than without (p=0.05)\
                               Endurance           Distance walked in 12 min                                      Endurance: N/S

  Drey *et al* [@R33]          Muscle power\       Lower limb sit-to-stand transfer power (force plate)\          Muscle power: increased with vitamin D intake (p=0.017)\
                               Muscle function\    SPPB, SF-LLFDI aLM (DXA)                                       Muscle function : SPPB increased with exercise (p=0.009), SF-LLFDI was N/S\
                               Body composition                                                                   Body composition: aLM was N/S

  Gianoudis *et al* [@R34]     Muscle strength\    Lower limbs (bilateral leg press)\                             Muscle strength: intervention increased strength relative to controls (p\<0.001)\
                               Muscle power\       Timed stair climb test\                                        Muscle power: Intervention increased power relative to controls (p\<0.05)\
                               Muscle function\    30 s sit-to-stand test, TUG\                                   Muscle function: intervention improved sit-to-stand relative to controls (p\<0.05) TUG: no between-group difference\
                               BMD\                Femoral neck and spine (DXA)\                                  BMD: intervention increased femoral neck relative to controls (p\<0.05) Spine: intervention increased relative to controls (p\<0.05)\
                               Body composition\   Total body lean and fat mass (DXA)\                            Body composition: lean and fat mass: N/S\
                               Dynamic balance     Four square step test                                          Dynamic balance: intervention increased relative to controls (p\<0.05)

  Jessup *et al* [@R35]        Muscle strength\    Hand grip (dynamometer), mean of 8 tests (stack machine)\      Muscle strength: increased with intervention (p=0.0156)\
                               BMD\                Femoral neck and spine (DXA)\                                  BMD femoral neck: increase with intervention (p=0.00001) Spine: no between-group difference\
                               Body sway           AccuSway force platform                                        Body sway: significantly reduced in intervention group (p=0.0027)

  Uusi-Rasi *et al* [@R21]     Muscle strength\    Max isometric leg extensor strength at a knee angle of 110°\   Muscle strength: increased with exercise (p\<0.001) Vitamin D supplementation N/S\
                               Muscle function\    SPPB, TUG\                                                     Muscle function : SPPB=N/S TUG: vitamin D without exercise increased relative to placebo without exercise (p=0.01)\
                               BMD\                Femoral neck and spine (BMD)\                                  BMD: femoral neck\
                               Dynamic balance     Backwards walking                                              Vitamin D maintained BMD (p=0.02) as did exercise (p=0.01) Spine: N/S\
                                                                                                                  Dynamic balance: improved with exercise (placebo: p=0.001, vitamin D: p=0.03). No additive effect of vitamin D

  Verschueren *et al* [@R36]   Muscle strength\    Isometric and dynamic knee extensor strength\                  Muscle strength: isometric: N/S Dynamic: N/S Vitamin D=no effect\
                               BMD\                Femoral neck (DXA)\                                            BMD: improved in all groups. No between-group difference\
                               Muscle mass         Mass of upper leg (multislice CT)                              Muscle mass: N/S
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

aLM, appendicular Lean Mass; BMD, bone mineral density; CSA, cross-sectional area; DXA, dual-energy X-ray absorptiometry; N/S, not significant; SPPB, short physical performance battery; SF-LLFDI, Short Form of the Late-Life Function and Disability Instrument; TUG, timed up and go.    

Risk of bias within studies {#s3e}
---------------------------

The risk of bias analyses are displayed in [table 4](#T4){ref-type="table"}. For all studies, a high proportion of components were assigned an unclear risk of bias due to insufficient information and the unknown effect on study outcome measures. Many studies reported insufficient information on concealment and blinding procedures, or whether procedures were in place in the event of unblinding. In total, six studies were judged to have an unclear risk of bias.[@R21] Component 1 was assessed as having a low risk of bias for all studies. One study was assessed as having an overall high risk of bias[@R34] due to component 5, as no data were entered into the analyses for participants with missing data.

###### 

Summary of risk of bias analysis for each included study

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year                 Components of risk of bias   Summary   Comments on high-risk components                                  
  ---------------------------- ---------------------------- --------- ---------------------------------- --- --- --- --- -------------- ---------------------------------------------------------------------------
  Agergaard *et al*)[@R31]     L                            U         L                                  L   U   L   L   High (0)\      N/A
                                                                                                                         Unclear (2)\   
                                                                                                                         Low (5)        

  Bunout *et al* [@R32]        L                            U         U                                  U   U   U   U   High (0)\      N/A
                                                                                                                         Unclear (6)\   
                                                                                                                         Low (1)        

  Drey *et al* [@R33]          L                            L         U                                  U   L   L   U   High (0)\      N/A
                                                                                                                         Unclear (3)\   
                                                                                                                         Low (4)        

  Gianoudis *et al* [@R34]     L                            U         U                                  U   H   L   L   High (1)\      One high-risk component, 5\
                                                                                                                         Unclear (3)\   ITT analysis used, but no data entered for participants with missing data
                                                                                                                         Low (3)        

  Jessup *et al* [@R35]        L                            U         U                                  U   U   U   L   High (0)\      N/A
                                                                                                                         Unclear (5)\   
                                                                                                                         Low (2)        

  Uusi-Rasi *et* a*l* [@R21]   L                            U         U                                  U   U   L   L   High (0)\      N/A
                                                                                                                         Unclear (4)\   
                                                                                                                         Low (3)        

  Verschueren *et al* [@R36]   L                            U         U                                  U   U   L   L   High (0)\      N/A
                                                                                                                         Unclear (4)\   
                                                                                                                         Low (3)        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ITT, intention to treat; N/A, not available.

GRADE analysis {#s3f}
--------------

The GRADE summary of findings for groups 1 and 2 are shown in [tables 5 and 6](#T5 T6){ref-type="table"}.

###### 

GRADE analysis of group 1 measurement outcomes included in the quantitative synthesis

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Quality assessment             **Summary of findings**                                                                                                                                                                                                                                                                                   
  ------------------------------ --------------------------- ---------------- --------------------------------------------------- ------------------------- ------------------------------------------------------------------- ------------------ ------------------------------- ------------------------- ----------- ----------------- ----------
  Outcome                        Included studies (design)   ROB              Inconsistency                                       No serious Indirectness   Imprecision                                                         Publication bias   Groups (intervention/control)   Effect size (direction)   p Value     95% CI            Quality

  Muscle strength (lower limb)   (RCT)[@R21]                 No serious ROB   Serious inconsistency (substantial heterogeneity)   No serious indirectness   No serious imprecision                                              Undetected\^       131/135                         0.98 (intervention)       \<0.00001   (0.73 to 1.24)    ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                           Moderate

  TUG                            (RCT)[@R21]                 No serious ROB   No serious inconsistency                            No serious indirectness   Serious imprecision (CIs crossline of no effect/ OIS not reached)   Undetected\^       124/125                         0.37 (intervention)       0.37        (−0.68 to 0.26)   ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                           Moderate

  BMD (femoral neck)             (RCT)[@R21]                 No serious ROB   No serious inconsistency                            No serious indirectness   Serious imprecision (CIs crossline of no effect/ OIS not reached)   Undetected\^       124/125                         0.02 (intervention)       0.15        (−0.01 to 0.05)   ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                           Moderate

  BMD (spine)                    (RCT)[@R21]                 No serious ROB   No serious inconsistency                            No serious indirectness   Serious imprecision (CIs crossline of no effect/ OIS not reached)   Undetected\^       124/125                         0.02 (intervention)       0.41        (−0.03 to 0.07)   ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                           Moderate
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\^ Insufficient 

BMD, bone mineral density; RCT, randomised controlled trial; OIS, Optimal Information Size; ROB, Risk Of Bias.

Within group 1, all studies were evaluated as moderate quality of evidence; no serious risk of bias was detected. Due to the nature of the studies included within this review, no serious indirectness was detected; all outcomes were measured directly without the use of a surrogate. Publication bias was not detected, and due to the number of studies included, it was not possible to produce funnel plots for any outcomes. Although publication bias was 'not detected', it is difficult to conclude that there was a complete absence of bias since studies with significant results are more likely to be published than those reporting null or non-significant results.[@R25] Published, peer-reviewed articles were included in this review, since the Cochrane Handbook for Systematic Reviews of Interventions further suggests that the inclusion of unpublished studies may introduce additional bias, as these studies have not been strengthened by the peer-review process and may be of lower methodological quality.[@R25] Reasons for downgrading the quality of evidence included serious inconsistency due to substantial heterogeneity, and serious imprecision due to CIs crossing the line of no effect.

Within group 2 studies, five outcomes were graded as high-to-moderate quality of evidence (SPPB, TUG, muscle strength of the lower limb, hand grip strength and BMD of the femoral neck). Remaining outcomes were graded as low or very low quality, meaning that one could have little or very little confidence in the effect estimate. Common reasons for downgrading outcomes included a combination of serious risk of bias (due to the inclusion of study[@R34]), serious imprecision or serious inconsistency.

###### 

GRADE analysis of group 2 measurement outcomes included in the quantitative synthesis

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Quality assessment             Summary of findings                                                                                                                                                                                                                                                                                                                                                      
  ------------------------------ -------------------------- ---------------------------------------------------------------------------- --------------------------------------------------- ------------------------- ------------------------------------------------------------------ ------------------ -------------------------------- ------------------------- ------------- ------------------- ----------
  Outcome                        Design, included studies   ROB                                                                          Inconsistency                                       Indirectness              Imprecision                                                        Publication bias   Groups (intervention/ control)   Effect size (direction)   **p Value**   **95%** CI          Quality

  SPPB                           (RCT)[@R32]                No serious ROB                                                               No serious inconsistency                            No serious indirectness   No serious imprecision                                             Undetected\^       45/46                            1.09 (intervention)       0.02          (0.15 to 2.03)      ⊕⊕⊕⊕\
                                                                                                                                                                                                                                                                                                                                                                                                          High

  TUG                            (RCT)[@R21] [@R32]         No serious ROB                                                               No serious inconsistency                            No serious indirectness   No serious imprecision                                             Undetected\^       124/126                          −1.57 (intervention)      p=0.001       (−2.50 to --0.64)   ⊕⊕⊕⊕\
                                                                                                                                                                                                                                                                                                                                                                                                          High

  Muscle strength (lower limb)   (RCT)[@R21]                No serious ROB                                                               Serious inconsistency (substantial heterogeneity)   No serious indirectness   No serious imprecision                                             Undetected\^       124/126                          2.69 (intervention)       0.002         (0.96 to 4.42)      ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                                                                                          Moderate

  Hand grip strength             (RCT)[@R32]                No serious ROB                                                               No serious inconsistency                            No serious indirectness   Serious imprecision (CI crossline of no effect, OIS not reached)   Undetected\^       31/33                            0.85 (intervention)       0.55          (−1.93 to 3.63)     ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                                                                                          Moderate

  Weight                         (RCT)[@R32]                Serious ROB [@R4] (was evaluated as high risk for incomplete outcome data)   No serious inconsistency                            No serious indirectness   Serious imprecision (CI crossline of no effect, OIS not reached)   Undetected\^       112/114                          −0.12 (intervention)      0.37          (−0.38 to 0.14)     ⊕⊕○○\
                                                                                                                                                                                                                                                                                                                                                                                                          Low

  Lean mass                      (RCT)[@R32]                Serious ROB [@R4] (was evaluated as high risk for incomplete outcome data)   No serious inconsistency                            No serious indirectness   Serious imprecision (CI crossline of no effect, OIS not reached)   Undetected\^       103/105                          0.02 (intervention)       0.98          (−1.31 to 1.35)     ⊕⊕○○\
                                                                                                                                                                                                                                                                                                                                                                                                          Low

  Fat mass                       (RCT)[@R32]                Serious ROB [@R4](was evaluated as high risk for incomplete outcome data)    No serious inconsistency                            No serious indirectness   Serious imprecision (CI crossline of no effect, OIS not reached)   Undetected\^       103/105                          −0.39 (intervention)      0.76          (−2.82 to 2.05)     ⊕⊕○○\
                                                                                                                                                                                                                                                                                                                                                                                                          Low

  BMD (femoral neck)             (RCT)[@R21]                Serious ROB [@R4](was evaluated as high risk for incomplete outcome data)    No serious inconsistency                            No serious indirectness   No serious imprecision                                             Undetected\^       124/126                          0.04 (intervention)       0.002         (0.01 to 0.06)      ⊕⊕⊕○\
                                                                                                                                                                                                                                                                                                                                                                                                          Moderate

  BMD (spine)                    (RCT)[@R21]                Serious ROB[@R4](was evaluated as high risk for incomplete outcome data)     Serious inconsistency (substantial heterogeneity)   No serious indirectness   Serious imprecision (CI crossline of no effect, OIS not reached)   Undetected\^       124/126                          0.02 (intervention)       0.24          (−0.001 to 0.05)    ⊕○○○\
                                                                                                                                                                                                                                                                                                                                                                                                          Very low
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\^Insufficient data to produce funnel plots.

BMD, bone mineral density; RCT, randomised controlled trial; SPPB, short physical performance battery; TUG, timed up and go.

Results of individual studies and synthesis of results {#s3g}
------------------------------------------------------

Results of the two groups of studies are reported separately. Qualitative syntheses were conducted for studies with similar interventions and outcomes measures using RevMan V.5.3 software. Study outcomes reporting results in the same units were pooled using a fixed-effect meta-analysis. Effect sizes are expressed as percentage mean differences or standardised mean differences (when outcomes were measured using different methods), with 95% CIs. Higher weighting was assigned to studies with smaller SD and a larger sample size.[@R25] Analyses were completed from extracted data, where necessary data were estimated from statistics or figures, or requested from the authors of the article. Heterogeneity was assessed via Χ^2^ test ([figures 2--14](#F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14){ref-type="fig"} and [tables 5 and 6](#T5 T6){ref-type="table"}). One article[@R36] was not included in any of the quantitative analyses, since the exercise intervention modality was considered to be too dissimilar to compare with the other included articles. Within each group, there were outcomes unsuitable for quantitative synthesis, due to a lack of studies with common outcomes or aspects of studies too dissimilar for comparison; therefore, a narrative analysis was used.

![Group 1 analysis of muscle strength of the lower limb.](bmjopen-2016-014619f02){#F2}

![Group 1 analysis of the TUG test.](bmjopen-2016-014619f03){#F3}

![Group 1 analysis of BMD of the femoral neck.](bmjopen-2016-014619f04){#F4}

![Group 1 analysis of BMD of the spine.](bmjopen-2016-014619f05){#F5}

![Group 2 analysis of the SPPB test.](bmjopen-2016-014619f06){#F6}

![Group 2 analysis of the timed up and go test.](bmjopen-2016-014619f07){#F7}

![Group 2 analysis of the muscle strength of the lower limb.](bmjopen-2016-014619f08){#F8}

![Group 2 analysis of hand grip strength.](bmjopen-2016-014619f09){#F9}

![Group 2 analysis of total body weight.](bmjopen-2016-014619f10){#F10}

![Group 2 analysis of lean mass.](bmjopen-2016-014619f11){#F11}

![Group 2 analysis of fat mass.](bmjopen-2016-014619f12){#F12}

![Group 2 analysis of bone mineral density of the femoral neck.](bmjopen-2016-014619f13){#F13}

![Group 2 analysis of bone mineral density of the spine.](bmjopen-2016-014619f14){#F14}

Quantitative synthesis {#s3h}
----------------------

Outcomes compared for group 1 included muscle strength of the lower limb, TUG and BMD of the femoral neck and spine ([figures 2--5](#F2 F3 F4 F5){ref-type="fig"}). Only muscle strength of the lower limb was found to be significant, with a large effect size in favour of the intervention group ([figure 2](#F2){ref-type="fig"}; 0.98, 95% CI 0.73, to 1.24, p\<0.00001).

Group 2 comparisons included the SPPB ([figure 6](#F6){ref-type="fig"}), TUG ([figure 7](#F7){ref-type="fig"}), muscle strength of the lower limb ([figure 8](#F8){ref-type="fig"}), hand grip strength ([figure 9](#F9){ref-type="fig"}), weight ([figure 10](#F10){ref-type="fig"}), lean mass ([figure 11](#F11){ref-type="fig"}), fat mass ([figure 12](#F12){ref-type="fig"}), BMD of the femoral neck ([figure 13](#F13){ref-type="fig"}) and spine ([figure 14](#F14){ref-type="fig"}). Of these outcomes, hand grip strength, weight, lean mass, fat mass and the BMD of the spine were found to be non-significant. However, SPPB score was more improved in the intervention group (1.09, 95% CI 0.15 to 2.03, p=0.02), with a significant and large effect. Similarly, TUG was significantly reduced within the intervention group (−1.57, 95% CI −2.50 to --0.64, p=0.0010). The results of the quantitative analysis also supported the combined intervention for muscle strength of the lower limb (2.69, 95% CI 0.95 to 4.42, p=0.002), and BMD of the femoral neck (0.04, 95% CI 0.01 to 0.06, p=0.002).

Qualitative synthesis {#s3i}
---------------------

Referring to the narrative synthesis guidelines provided by the Cochrane Consumers and Communication Review Group,[@R37] it was appropriate to apply two steps listed; developing a preliminary synthesis and exploring the relationships within and between studies. To develop a primary synthesis, results were systematically tabulated to identify patterns across studies ([tables 7--9](#T7 T8 T9){ref-type="table"}). Exploring the relationships between and within studies for group 1, the control group in study[@R31] demonstrated a significant percentage increase in CSA of the quadriceps from baseline in comparison with the intervention group (+8.46% vs +4.94%, p\<0.05).

###### 

Narrative analysis summary of findings for group 1 secondary outcome measures

  Category           Outcome measure                     Assessment point   Study                           Intervention group % change from baseline   Control group % change from baseline                        
  ------------------ ----------------------------------- ------------------ ------------------------------- ------------------------------------------- -------------------------------------- --- --------- ------ ----
  Body composition   CSA of quadriceps muscles (cm^2^)   16 weeks           Agergaard *et al,* 2015[@R31]   +4.94                                       5.28                                   7   +8.46\*   6.80   10

Group 1 studies compared vitamin D3 supplementation and exercise training vs exercise alone.

\* *p* \< 0.05

CSA, cross-sectional area.

###### 

Narrative analysis summary of findings for group 2 primary outcome measures

  Category                                     Outcome                                 Assessment point                Study                             Intervention group % change from baseline   Control group % change from baseline                            
  -------------------------------------------- --------------------------------------- ------------------------------- --------------------------------- ------------------------------------------- -------------------------------------- -------- ------- ------- ----
  Muscle strength                              Isometric knee extensor strength (Nm)   6 months                        Verschueren *et al*, 2011[@R36]   +3.01                                       2.67                                   28       +0.11   3.18    28
  Muscle power                                 Sit-to-stand transfer power (W)         12 weeks                        Drey *et al*, 2011[@R33]          +8.99\*                                     5.51                                   23       +2.61   2.49    22
  Functional stair climbing muscle power (W)   12 months                               Gianoudis *et al*, 2014[@R34]   +10.40\*                          13.00                                       81                                     +6.20    12.70   81      
  Muscle function                              30 s sit-to-stand (n. stands)           12 months                       Gianoudis *et al*, 2014[@R34]     +18.30\*                                    23.60                                  81       +2.70   17.2    81
  5-time chair stand time (s)                  24 months                               Uusi-Rasi *et al*, 2015[@R21]   −6.95                             2.50                                        102                                    −3.49    3.30    102     
  Normal walking speed (m/s)                   24 months                               Uusi-Rasi *et al*, 2015[@R21]   −1.80                             0.20                                        102                                    −3.30    0.21    102     
  Endurance: 12 min walk (m)                   9 months                                Bunout *et al*, 2006[@R32]      +8.80                             17.60                                       22                                     +20.90   27.70   24      
  Balance                                      Romberg ratio (%)                       9 months                        Bunout *et al*, 2006[@R32]        +2.80                                       33.80                                  22       −0.60   35.80   
  Four-square step test (s)                    12 months                               Gianoudis *et al*, 2014[@R34]   −12.00\*                          14.10                                       81                                     −5.20    14.90   81      
  Body sway (cm)                               32 weeks                                Jessup *et al*, 2003[@R35]      −26.39\*                          0.52                                        9                                      +2.90    0.49    9       
  Backwards walking (% able to complete)       24 months                               Uusi-Rasi *et al*, 2015[@R21]   +25.47\*                          13.59                                       102                                    +9.48    15.58   102     

Group 2 compared vitamin D~3~ supplementation and exercise training vs vitamin D~3~ supplementation alone.

\* *p* \< 0.05

###### 

Narrative analysis summary of findings for group 2 secondary outcomes

  Category                            Outcome measure               Assessment point                  Study                      Intervention group % change from baseline   Control group % change from baseline                          
  ----------------------------------- ----------------------------- --------------------------------- -------------------------- ------------------------------------------- -------------------------------------- ------- ------- ------ ----
  Body composition                    Appendicular lean mass (kg)   12 weeks                          Drey *et al*, 2011[@R33]   +1.65                                       0.71                                   23      +0.00   0.87   22
  Muscle mass of upper limb (cm^3^)   6 months                      Verschueren *et al*, 2011[@R36]   −0.16                      0.57                                        28                                     −0.25   0.38    28     
  BMD of femoral neck (g/cm^2^)       6 months                      Verschueren *et al*, 2011[@R36]   +0.71                      0.42                                        28                                     +0.99   0.51    28     

Group 2 compared vitamin D~3~ supplementation and exercise training vs vitamin D~3~ supplementation alone.

BMD, bone mineral density.

Comparing primary outcomes for group 2, the percentage increase in isometric knee extensor strength for study[@R36] was greater in the intervention group (+3.01% vs +0.11%), although not statistically significant. Muscle power was compared in studies[@R33] and expressed as sit-to-stand transfer power and functional stair climbing muscle power, respectively[@R34]. Both studies reported a significant percentage increase in muscle power within the intervention groups, and smaller, non-significant increases within the control groups (sit-to-stand transfer power intervention group +8.00% vs +2.61%, p=0.017; functional stair climbing muscle power intervention group +10.51% vs +7.32%, p\<0.05).

The 30 s sit-to-stand test showed significant favourable results for the combined intervention of exercise and vitamin D~3~ (+10.40% vs +6.20%, p\<0.05). Within study,[@R21] normal walking speed declined in both groups and the 5-time chair stand time was improved non-significantly in both groups. The 12 min walk test in study[@R32] was further improved within the control group, although this did not achieve statistical significance. The four-square step test, body sway and backward walking were significantly more improved in the intervention groups. Only Romberg ratio showed the greatest improvement within the control group; Romberg ratio was decreased in comparison with the intervention group, although the results were non-significant (+2.8% vs −0.60%).

For group 2 secondary outcomes, small and non-significant gains in appendicular lean mass were demonstrated in the intervention group of study.[@R33] In study,[@R36] muscle mass of the upper limb decreased non-significantly in both the intervention and control groups, although to a lesser extent in the intervention group. BMD of the femoral neck was gained in both groups, although by a higher percentage in the control group; both trends were non-significant.

In summary, meta-analyses for group 1 found muscle strength of the lower limb to be significantly improved within the intervention group (0.98, 95% CI 0.73 to 1.24, p\<0.001). All other outcomes showed small but non-significant positive effects for the intervention group. The SPPB, TUG, muscle strength of the lower limb and femoral neck BMD all showed significantly greater improvements in the intervention group for group 2 comparisons.

The narrative analysis revealed significant differences in body composition, muscle power, muscle function and balance. A significant percentage increase in quadriceps CSA was observed in the control group of study.[@R31] The combined intervention of RET and vitamin D~3~ supplementation resulted in a greater percentage increase in muscle strength and power, and a greater improvement in the 30 s sit-to-stand test, the four-square step test, body sway and backward walking. However, vitamin D~3~ supplementation alone resulted in a greater improvement in the 12 min walk test and Romberg ratio.

Discussion {#s4}
==========

The aim of this systematic review was to assess the combined effect of RET and vitamin D~3~ supplementation on musculoskeletal health in older adults. Only seven studies were eligible for inclusion, with a total of 792 participants, highlighting the lack of available literature on the topic. Studies were categorised into two groups: studies in which all participants took part in RET and the intervention group was supplemented with vitamin D~3~, or studies in which all participants were supplemented with vitamin D~3~ and the intervention group took part in RET. Two studies were categorised into both group 1 and group 2.

Quantitative analysis {#s4a}
---------------------

Data analysis conducted for this review included meta-analyses and narrative reviews. Meta-analyses for group 1 included muscle strength of the lower limb, TUG and BMD of both the femoral neck and spine. Evidence of additional benefit was shown for all outcomes within the intervention group; however, the effect size was small and non-significant for TUG and BMD of the femoral neck and spine. Muscle strength of the lower limb was the only significant outcome of group 1, with a large effect size observed within the intervention group (0.98, 95% CI 0.73, to 1.24, p\<0.00001). Although numerous studies have demonstrated the beneficial effect of RET on muscle strength in older adults,[@R3] this result provides evidence that vitamin D~3~ supplementation may enhance these effects in older adults. Skeletal muscle myopathies associated with vitamin D deficiency are well documented,[@R38] and symptoms of significant muscle weakness are reversed with treatment of the deficiency.[@R39] A systematic review and meta-analysis reported a gain in lower extremity strength with vitamin D supplementation only in vitamin D deficient older adults; no effect was observed in replete adults.[@R22] Similarly, no effect of vitamin D~3~ supplementation on isometric quadriceps strength was demonstrated after 6 months in vitamin D replete older adults.[@R40] Interestingly, although the studies included within group 1[@R21] did not specify serum 25(OH)D levels as inclusion/exclusion criteria, baseline and postintervention serum 25(OH)D were within the 'sufficient' range (\>30 nmol/L). A greater increase of muscle strength in replete older adults represents a novel finding of this review. Preliminary support for combined vitamin D supplementation and RET was demonstrated in a 3-month longitudinal study examining the effect of serum 25(OH)D and exercise training on functional performance in older men and women aged 65 years and over. No significant improvements in function were reported in participants with lower serum 25(OH)D (\<47.5 nmol/L); however, higher serum 25(OH)D (\>67.5 nmol/L) was associated with greatest improvements in functionality and muscle strength.[@R41]

This finding must be considered within the context of the risk of bias and GRADE analyses. The risk of bias analysis showed an overall unclear risk of bias for the included studies, and the GRADE analysis concluded that the evidenced was of moderate quality; however, serious inconsistency due to moderate heterogeneity (I^2^=70%) was detected. This heterogeneity may have been due to the differing duration of interventions (12 weeks to 24 months), differences between measurement methodologies, differences between exercise regimens (although all adopted progressive RET), doses of vitamin D~3~ (400--1920 IU/day) or may indicate that these studies were unsuitable for comparison.

Significant effects for the SPPB, TUG, muscle strength of the lower limb and the BMD of the femoral neck were observed within the intervention groups of group 2 studies; unsurprisingly, RET was found to have a positive influence. In a recent systematic review and meta-analysis, exercise significantly increased SPPB score and decreased TUG time, with large effect sizes (1.87 and −2.47 , respectively[@R42]); similar results are reported within this review. Vitamin D is a regulator of BMD, proliferating calcium and phosphate absorption in the intestine and acting directly on bone cells.[@R43] Vitamin D has previously been shown to influence BMD, fracture rate and risk[@R44]; studies of patients who have sustained a hip fracture typically demonstrated low serum vitamin D (≤30.0 nmol/L[@R45]). Supplementation of vitamin D and calcium has been shown to significantly decrease the rate of bone loss in the hip and spine.[@R46] GRADE analyses for these outcomes concluded the quality of evidence to be high (SPPB and TUG) or moderate (muscle strength of the lower limb and BMD of the femoral neck).

Closer examination of the control groups within significant outcomes for group 2 was undertaken to evaluate the effect of vitamin D~3~ supplementation alone. Intriguingly, although the intervention groups (RET and vitamin D~3~ supplementation) showed evidence of benefit in number of outcomes, the control groups (vitamin D~3~ supplementation alone) showed mixed, or even negative impacts on the same outcomes. SPPB score was decreased postintervention compared with baseline by 0.30% and 0.50% in the control groups of studies[@R32] and[@R33], respectively. Muscle strength of the lower limb and BMD of the femoral neck showed mixed results for the intervention groups, with some studies reporting small increases and others reporting small losses (non-significant). Previous reports of the effect of vitamin D supplementation on muscle strength and physical functioning are mixed; the InCHIANTI study of people aged 65 years or over reported a significant association between serum 25(OH)D\<25 nmol/L and SPPB score.[@R47] Similarly, a large prospective cohort of older adults aged 65 years or over found those with low (\<25 nmol/L) 25(OH)D were significantly more likely to experience losses in grip strength and higher rates of appendicular lean mass loss compared with those with higher (\>50 nmol/L) 25(OH)D.[@R23] Conversely, another large, prospective study found no association between serum 25(OH)D, walking speed and time for repeated chair stands.[@R48] The TUG test time increased in all groups of study,[@R32] and was significantly increased in the vitamin D without exercise group in study (p=0.01).[@R21] Again, participants included in studies[@R32] and[@R21] had sufficient serum 25(OH)D levels, indicating that supplementation in replete older adults may not confer additional benefits to neuromuscular function unless combined with exercise.

Narrative analysis {#s4b}
------------------

Studies in group 1[@R21] had few body composition outcomes in common, therefore, a narrative analysis was conducted. The CSA of the quadriceps was analysed within study,[@R31] and results showed that although the intervention group did experience a +4.94%, increase from baseline, the control group (not supplemented with vitamin D~3~) actually showed a significantly higher increase in quadriceps CSA (+8.46%, p\<0.05).

These results do not provide evidence for the additive effects of combined exercise training and vitamin D~3~. Other study groups have reported changes in muscle CSA consequent to RET, which are both smaller[@R8] and comparable[@R50] to those reported in study.[@R31] Interestingly, study[@R31] also assessed 'muscle quality' (muscle strength/CSA), although non-significant, the intervention group improved their muscle quality to a greater degree than the control group (+9.61% vs +0.66% change from baseline), indicating an increased functionality of the muscle to produce force; conceptually more relevant in combatting the effects of sarcopenia than muscle size and strength alone.[@R51]

Results of the narrative analysis for group 2 showed that the combined intervention of RET and vitamin D~3~ supplementation was significantly more beneficial than vitamin D~3~ supplementation alone for sit-to-stand transfer power, functional stair climbing muscle power, 30 s sit-to-stand, 5-time chair stand, the four-square step test, body sway and backward walking. Only body sway was negatively affected by vitamin D~3~ supplementation, although the within-group change was non-significant. Other outcomes of interest included normal walking speed, which deteriorated in both groups, the distance walked in 12 min and Romberg ratio, in which the control groups made the most improvement, although not significantly.

Limitations {#s4c}
-----------

Few published studies were eligible for inclusion within this review, although this serves to highlight the knowledge gap with respect to this topic. The inclusion of a high-risk study was deemed necessary due to the lack of available literature, although this had a negative effect on the perceived quality of evidence for the outcomes in which it was reported. Generally, outcome measure data could be graded as representing moderate quality, although there were several outcome measures graded as low or very low quality, due to the high variability of participant numbers, duration of interventions, exercise methodologies or differing vitamin D~3~ doses and period of supplementation employed within the studies. Furthermore, data produced from meta-analyses including study[@R21] may have been skewed due to the high weighting assigned for this study as a result of the large number of participants recruited.

Of the individual studies included within this review, none reported inclusion/exclusion criterion for vitamin D status, and although at baseline serum vitamin D was not significantly different between the groups in five studies,[@R21] two studies reported no data for serum vitamin D preintervention or postintervention.[@R34] Additionally, analysis methods used within five studies included did not account for confounding factors,[@R31] and participants were not stratified on the basis of any characteristics in three studies,[@R21] although these were single-sex studies. Unfortunately, several outcome measures were unsuitable for inclusion within the qualitative analysis due to differing measurement methodologies used or too few outcome measures in common. A recent systematic review and meta-analysis investigating the effects of vitamin D on neuromuscular remodelling following exercise or injury similarly found few eligible studies and high levels of heterogeneity due to methodological differences, resulting in the authors to suggest more high-quality evidence is needed to reach a result that is conclusive.[@R52]

Conclusion {#s5}
==========

This review provides tentative support for the additive effect of combined RET and vitamin D~3~ supplementation for the improvement of muscle strength in older adults. For other aspects of musculoskeletal function, such as SPPB and TUG, no additional benefit beyond that gained from exercise training was found. This review showed no evidence of benefit of vitamin D~3~ supplementation alone, however, few studies were identified during the literature search, highlighting that further evidence is required to draw any firm conclusions or make explicit recommendations regarding vitamin D~3~ supplementation for musculoskeletal health and function in older adults.

Our recommendations to enable future studies to definitively answer questions regarding the additive effects of the combined vitamin D~3~ supplementation and RET include common outcomes relevant to the condition studied, for example, the SPPB, 400 m walk and gait speed are recommended to assess physical performance,[@R53] which would allow for a more detailed assessment of results. Additionally, exercise interventions of similar durations would allow for a more accurate comparison between studies; it has been suggested that interventions with older adults should be of a minimum duration of 3 months to obtain significant differences in relevant outcomes.[@R53] Reporting of confounding factors would allow for adjustment of results via the use of covariates, for example, objective measures of physical activity using accelerometers, baseline serum vitamin D~3~ status and participant characteristics, which may bias the participant pool. Separate analysis of male and female participants, or the addition of sex as a covariate in any analysis models would help to address sex-related differences in performance. Regarding study design, four-armed RCT studies are best placed to answer combined effects research questions, that is, exercise intervention, vitamin D intervention, both exercise and vitamin D, neither exercise nor vitamin D (true control). A true control group was lacking from a number of the included studies within this review.
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